Pipeline

Precision-Engineered GPCR-Targeted Therapeutics

Our science and technology have enabled us to produce a diversified portfolio of development programs, targeting previously-undruggable GPCRs and addressing an underserved market.

Drug / Target

indication

Phase

Oncology

IND Enabling

OB-002 / CCR5

Infections Disease

Ph1 Trial Complete

COVID-19 ARDS

PoC Complete

Neuroinflam

PoC Complete

OB-003 / CCR9

Oncology

Lead Optimization

IBD

Lead Optimization

OB-004 / CCR2

Oncology

PoC

Inflammation

PoC

Undisclosed

Oncology

Target Validation

Metabolic

Target Validation

Undisclosed Orphan

Oncology

Lead Discovery

Oncology2

Target Validation

DRUG / TARGET

DISCOVERY

PoC

IND Enabling

Clinical Trials
Phase 1  Phase 2/3

OB-002 / CCR5

oncology

Infectious Disease

COVID-19 ARDS

Neuroinflammation

OB-003 / CCR9

Oncology

IBD

OB-004 / CCR2

Oncology

Inflammation

Undisclosed

Oncology

Metabolic

Undisclosed Orphan

Oncology 1

Oncology 2

Global Headquarters

343 Preston Street

11th floor,

Ottawa, On K1S 1N4

CANADA

+1 343.291.1032

Switzerland

Campus Biotech

Innovation Park

Avenue de Sécheron 15

1202 Genève

SWITZERLAND

Poland

Orion Biotechnology

Life Science Park

UI Bobrzyńskiego 14

30-348 Krakôw

POLAND

© 2023 Orion Biotechnology Canada, Ltd. All rights reserved.

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032

This website uses cookies to ensure you get the best experience on our site.  By using this website, you agree to our use of cookies.

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032